Literature DB >> 12082132

Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites.

Pascal Michon1, Jamie R Stevens, Osamu Kaneko, John H Adams.   

Abstract

Malaria parasites invade erythrocytes in a process mediated by a series of molecular interactions. Invasion of human erythrocytes by Plasmodium vivax is dependent upon the presence of a single receptor, but P. falciparum, as well as some other species, exhibits the ability to utilize multiple alternative invasion pathways. Conserved cysteine-rich domains play important roles at critical times during this invasion process and at other stages in the life cycle of malaria parasites. Duffy-binding-like (DBL) domains, expressed as a part of the erythrocyte-binding proteins (DBL-EBP), are such essential cysteine-rich ligands that recognize specific host cell surface receptors. DBL-EBP, which are products of the erythrocyte-binding-like (ebl) gene family, act as critical determinants of erythrocyte specificity and are the best-defined ligands from invasive stages of malaria parasites. The ebl genes include the P. falciparum erythrocyte-binding antigen-175 (EBA-175) and P. vivax Duffy-binding protein. DBL domains also mediate cytoadherence as a part of the variant erythrocytic membrane protein-1 (PfEMP-1) antigens expressed from var genes on the surface of P. falciparum-infected erythrocytes. A paralogue of the ebl family is the malarial ligand MAEBL, which has a chimeric structure where the DBL domain is functionally replaced with a distinct cysteine-rich erythrocyte-binding domain with similarity to the apical membrane antigen-1 (AMA-1) ligand domain. The Plasmodium AMA-1 ligand domain, which encompasses the extracellular cysteine domains 1 and 2 and is well conserved in a Toxoplasma gondii AMA-1, has erythrocyte-binding activity distinct from that of MAEBL. These important families of Plasmodium molecules (DBL-EBP, PfEMP-1, MAEBL, AMA-1) are interrelated through the MAEBL. Because MAEBL and the other ebl products have the characteristics expected of homologous ligands involved in equivalent alternative invasion pathways to each other, we sought to better understand their roles during invasion by determining their relative origins in the Plasmodium genome. An analysis of their multiple cysteine-rich domains permitted a unique insight into the evolutionary development of PLASMODIUM: Our data indicate that maebl, ama-1, and ebl genes have ancient origins which predate Plasmodium speciation. The maebl evolved as a single locus, including its unique chimeric structure, in each Plasmodium species, in parallel with the ama-1 and the ebl genes families. The ancient character of maebl, along with its different expression characteristics suggests that MAEBL is unique and does not play an alternative role in invasion to ebl products such as EBA-175. The multiple P. falciparum ebl paralogues that express DBL domains, which have occurred by duplication and diversification, potentially do provide multiple functionally equivalent ligands to EBA-175 for alternative invasion pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082132     DOI: 10.1093/oxfordjournals.molbev.a004171

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  25 in total

1.  Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides.

Authors:  Hernando Curtidor; Luis E Rodríguez; Marisol Ocampo; Ramses López; Javier E García; John Valbuena; Ricardo Vera; Alvaro Puentes; Magnolia Vanegas; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

2.  The structure of the Plasmodium falciparum EBA175 ligand domain and the molecular basis of host specificity.

Authors:  Debasish Chattopadhyay; Julian Rayner; Amy M McHenry; John H Adams
Journal:  Trends Parasitol       Date:  2006-02-23

3.  The crystal structure of P. knowlesi DBPalpha DBL domain and its implications for immune evasion.

Authors:  Amy M McHenry; John H Adams
Journal:  Trends Biochem Sci       Date:  2006-07-27       Impact factor: 13.807

4.  Dissecting the interface between apicomplexan parasite and host cell: Insights from a divergent AMA-RON2 pair.

Authors:  Michelle L Parker; Diana M Penarete-Vargas; Phineas T Hamilton; Amandine Guérin; Jitender P Dubey; Steve J Perlman; Furio Spano; Maryse Lebrun; Martin J Boulanger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

5.  Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein.

Authors:  Jia Xainli; Jennifer L Cole-Tobian; Moses Baisor; Will Kastens; Moses Bockarie; Syed Shams Yazdani; Chetan E Chitnis; John H Adams; Christopher L King
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket.

Authors:  Tao Bai; Michael Becker; Aditi Gupta; Phillip Strike; Vince J Murphy; Robin F Anders; Adrian H Batchelor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

7.  Identification and expression of maebl, an erythrocyte-binding gene, in Plasmodium gallinaceum.

Authors:  Criseyda Martinez; Timothy Marzec; Christopher D Smith; Lisa A Tell; Ravinder N M Sehgal
Journal:  Parasitol Res       Date:  2012-12-07       Impact factor: 2.289

8.  Diversity and evolution of the rhoph1/clag multigene family of Plasmodium falciparum.

Authors:  Hideyuki Iriko; Osamu Kaneko; Hitoshi Otsuki; Takafumi Tsuboi; Xin-Zhuan Su; Kazuyuki Tanabe; Motomi Torii
Journal:  Mol Biochem Parasitol       Date:  2007-11-17       Impact factor: 1.759

9.  Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems.

Authors:  Anjali Yadava; Christian F Ockenhouse
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro.

Authors:  Peter Preiser; Laurent Rénia; Naresh Singh; Bharath Balu; William Jarra; Tatiana Voza; Osamu Kaneko; Peter Blair; Motomi Torii; Irène Landau; John H Adams
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.